Hide metadata

dc.date.accessioned2015-11-17T19:10:27Z
dc.date.available2015-11-17T19:10:27Z
dc.date.issued1997
dc.identifier.urihttp://hdl.handle.net/10852/47784
dc.language.isoenen_US
dc.publisherMatematisk Institutt, Universitetet i Oslo
dc.relation.ispartofPreprint series. Statistical Research Report http://urn.nb.no/URN:NBN:no-23420
dc.relation.urihttp://urn.nb.no/URN:NBN:no-23420
dc.titleAssessment of the scientific documentation of the drugs etidronat (Didronate) and alendronat (Fosamax) for the reduction of the number of fractures among women with osteoporosis. An analysis based on Bayesian statistics.en_US
dc.typeResearch reporten_US
dc.creator.authorStorvik, Geir
dc.creator.authorNatvig, Bent
dc.creator.authorGåsemyr, Jørund
dc.creator.authorAursnes, Ivar
dc.identifier.urnURN:NBN:no-51799
dc.type.documentForskningsrapporten_US
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/47784/1/1997-9.pdf


Files in this item

Appears in the following Collection

Hide metadata